RecruitingNot ApplicableNCT06759805

Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study

eCardiacRehab - a Pragmatic Trial on a Home-based Patient-centered e-Health Programme With Tailored Solutions - Feasibility Study


Sponsor

Haukeland University Hospital

Enrollment

80 participants

Start Date

Jan 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In Norway, more than 11,000 patients undergo percutaneous coronary intervention (PCI) annually. However, a very recent study utilizing registry data show a national average of cardiac rehabilitation (CR) participation of only 14%, despite its proven beneficial effects on readmissions, physical capacity, psychological distress, self-management, and quality of life. CR is strongly recommended in European guidelines. However, uptake is low and is not systematically identifying those in most need of CR. The primary objective of eCardiacRehab is to meet rehabilitation needs of large patient populations regardless of their access to traditional place-based rehabilitation by developing and evaluating the efficacy and cost effectiveness of an interdisciplinary and comprehensive home-based eCardiacRehab programme. eCardiacRehab address patient- and system level challenges in order to increase access to CR. The investigators give particular attention to older patients, women, and those with comorbidities or mental health challenges. Aspects related to continuity of care between specialist and primary care services, health literacy, adherence to treatment, cost effectiveness and ethics are investigated. The investigators will 1) continue to develop the programme with patients, general practitioners, healthcare experts from both specialist and primary care services, and technology developers, 2) develop treatment modules, 3) establish information and communication infrastructure, 4) evaluate the process and efficacy of treatment modules, 5) ensure knowledge development and transfer of competence to the municipalities, and 6) contribute to fulfil the innovation potential for health service and industry partners. eCardiacRehab has the potential to improve interaction and collaboration between primary and secondary care, modernise and digitalise work processes, and develop more coherent and tailored patient pathways. The vision of the home-based eCardiacRehab is to make CR available to all.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a digital, home-based cardiac rehabilitation program (eCardiacRehab) is practical and acceptable for people in Norway who have had a heart stent procedure (percutaneous coronary intervention, or PCI) for coronary artery disease. **You may be eligible if...** - You are 18 or older and speak Norwegian or Scandinavian - You have coronary artery disease and recently underwent a PCI (heart stent) procedure - You are living at home with internet access - You agree to participate **You may NOT be eligible if...** - You have significant cognitive impairment - You have severe heart valve disease (aortic stenosis) or dangerous heart rhythm problems - Your expected life expectancy is less than one year - Your heart revascularization is not yet complete (you are still awaiting further stent or bypass surgery) - A physical disability or mental health condition prevents you from following the study protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEReCardiacRehab

Interdisciplinary supervised home-based digital secondary prevention programme (12-week programme) based on the European Society of Cardiology guidelines for cardiac rehabilitation for patients after percutaneous coronary intervention.


Locations(1)

Haukeland University Hospital

Bergen, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06759805


Related Trials